Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice
- PMID: 6601189
Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice
Abstract
C3H mice develop heavier degrees of Pneumocystis carinii pneumonia than other mouse strains tested. We have compared P. carinii pneumonia in two strains of C3H mice: C3H/HeJ mice, which are unresponsive to the effects of bacterial lipopolysaccharide (LPS), have defects in macrophage function, and have increased antibody responses to orally administered T-dependent antigens; and C3HeB/FeJ mice, which are immunologically normal. P. carinii pneumonia was induced by corticosteroids, and the intensity of the infection was judged by a semiquantitative histopathologic scoring system. Heavier degrees of infection were found in C3H/HeJ mice than in C3HeB/FeJ mice. Serum antibodies to P. carinii, measured by an indirect fluorescent antibody technique, were mainly of the IgG class in both strains of mice and varied inversely with the intensity of P. carinii infection in the lungs. Antibody levels were significantly higher in C3H/HeJ mice than in C3HeB/FeJ mice. These data suggest that C3H/HeJ have increased susceptibility to the effects of steroids of host defenses against P. carinii, and heightened serum antibody responses to the organism.
Similar articles
-
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections.J Immunol. 1985 Jun;134(6):4118-22. J Immunol. 1985. PMID: 3886795
-
Hematopoietic response of splenectomized C3HeB/FeJ and C3H/HeJ mice to lipopolysaccharide.Exp Hematol. 1981 Oct;9(9):950-5. Exp Hematol. 1981. PMID: 7338273
-
Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.J Immunol. 1988 Mar 1;140(5):1638-44. J Immunol. 1988. PMID: 3279120
-
Lymphocytes in host defense against Pneumocystis carinii.Semin Respir Infect. 1998 Dec;13(4):330-8. Semin Respir Infect. 1998. PMID: 9872630 Review.
-
Attachment of microbes to host cells: relevance of Pneumocystis carinii.Lab Invest. 1986 Jun;54(6):589-92. Lab Invest. 1986. PMID: 2423776 Review. No abstract available.
Cited by
-
Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.Antimicrob Agents Chemother. 1997 Feb;41(2):251-8. doi: 10.1128/AAC.41.2.251. Antimicrob Agents Chemother. 1997. PMID: 9021175 Free PMC article.
-
Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.Infect Immun. 1993 May;61(5):1641-9. doi: 10.1128/iai.61.5.1641-1649.1993. Infect Immun. 1993. PMID: 8478052 Free PMC article.
-
Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.Infect Immun. 1992 Apr;60(4):1589-97. doi: 10.1128/iai.60.4.1589-1597.1992. Infect Immun. 1992. PMID: 1548080 Free PMC article.